MYGN

SEC source: 0001738340-26-000004 · wk-form4_1773695121.xml · nonDerivative · entry 1

Raha Samraat S. · CIK 0001738340 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,111,661

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001738340-26-000002 · wk-form4_1773097390.xml · nonDerivative · entry 1

Raha Samraat S. · CIK 0001738340 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493,104

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001472827-26-000002 · wk-form4_1772486306.xml · nonDerivative · entry 1

Solaiman Shereen · CIK 0001472827 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,288

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on February 27, 2026.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 3

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,951

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.79, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 2

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,951

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $5.01, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001471518-26-000002 · wk-form4_1772228775.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,544

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.725 to $4.75, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002082246-26-000002 · wk-form4_1770157811.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,624

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

SEC source: 0001517026-26-000002 · wk-form4_1770157806.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,636

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

SEC source: 0001922964-26-000004 · wk-form4_1770157800.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,878

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

SEC source: 0001843872-26-000003 · wk-form4_1770157795.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,332

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

SEC source: 0001922964-26-000002 · wk-form4_1767388657.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,181

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2025.

SEC source: 0002082246-25-000008 · wk-form4_1767043825.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,630

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 24, 2025.

SEC source: 0001738340-25-000009 · wk-form4_1765576030.xml · nonDerivative · entry 1

Raha Samraat S. · CIK 0001738340 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,104

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 11, 2025.

SEC source: 0001517026-25-000008 · wk-form4_1758572179.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,826

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

SEC source: 0001932320-25-000006 · wk-form4_1758572110.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,167

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

SEC source: 0002082246-25-000006 · wk-form4_1758572074.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,651

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

SEC source: 0001843568-25-000006 · wk-form4_1758572042.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · EVP, Strategy & Transformation

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,726

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

SEC source: 0001914879-25-000004 · wk-form4_1757016855.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,481

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 3, 2025.

SEC source: 0002082246-25-000004 · wk-form4_1755638655.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,210

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-25-029981 · wk-form4_1749240341.xml · nonDerivative · entry 1

Dreismann Heinrich · CIK 0001379372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,444

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029979 · wk-form4_1749240326.xml · nonDerivative · entry 1

Bisaro Paul · CIK 0001237253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,941

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029977 · wk-form4_1749240308.xml · nonDerivative · entry 1

Davis Mark Steven · CIK 0002024613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,964

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029975 · wk-form4_1749240296.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,444

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029974 · wk-form4_1749240285.xml · nonDerivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,141

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029972 · wk-form4_1749240262.xml · nonDerivative · entry 1

Kumar Rashmi · CIK 0001824720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,188

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029973 · wk-form4_1749240274.xml · nonDerivative · entry 1

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,329

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001628280-25-029971 · wk-form4_1749240252.xml · nonDerivative · entry 1

Skovronsky Daniel · CIK 0001741474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,806

F1 · shares: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001738340-25-000006 · wk-form4_1748895880.xml · nonDerivative · entry 1

Raha Samraat S. · CIK 0001738340 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 482,738

F1 · shares: These shares were acquired under the Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0002065630-25-000004 · wk-form4_1746216907.xml · derivative · entry 3

Donnelly Brian J · CIK 0002065630 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,167

Underlying: Common Stock · 236,167 shares

Expires not disclosed

F3 · derivative.exercise_price: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026.

F3 · derivative.exercise_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026.

F3 · derivative.expiration_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026.

SEC source: 0002065630-25-000004 · wk-form4_1746216907.xml · nonDerivative · entry 2

Donnelly Brian J · CIK 0002065630 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,534

F2 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0002065630-25-000004 · wk-form4_1746216907.xml · nonDerivative · entry 1

Donnelly Brian J · CIK 0002065630 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,905

F1 · shares: Consists of time-based restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001517026-25-000005 · wk-form4_1746131228.xml · derivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,785

Underlying: Common Stock · 105,785 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

F1 · derivative.exercise_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

F1 · derivative.expiration_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

SEC source: 0001738340-25-000003 · wk-form4_1746131053.xml · derivative · entry 1

Raha Samraat S. · CIK 0001738340 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,050

Underlying: Common Stock · 141,050 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

F1 · derivative.exercise_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

F1 · derivative.expiration_date: The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

SEC source: 0001922964-25-000004 · wk-form4_1744748070.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,599

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025.

SEC source: 0001517026-25-000002 · wk-form4_1744747947.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,911

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025.

SEC source: 0001932320-25-000002 · wk-form4_1743020344.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,129

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 25, 2025.

SEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 4

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,491

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 3

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,080

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 4

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,635

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014727 · wk-form4_1742933813.xml · nonDerivative · entry 3

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,359

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 4

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,541

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014726 · wk-form4_1742933802.xml · nonDerivative · entry 3

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,341

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014724 · wk-form4_1742933792.xml · nonDerivative · entry 4

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,996

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014724 · wk-form4_1742933792.xml · nonDerivative · entry 3

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 385,601

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014723 · wk-form4_1742933780.xml · nonDerivative · entry 4

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 891,844

F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014723 · wk-form4_1742933780.xml · nonDerivative · entry 3

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 918,671

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025.

SEC source: 0001628280-25-014730 · wk-form4_1742933838.xml · nonDerivative · entry 2

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,684

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

SEC source: 0001628280-25-014730 · wk-form4_1742933838.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,588

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

SEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 2

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,473

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.

SEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,608

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025.